{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:40:21Z","timestamp":1790170821044,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10753-020-01301-1","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T06:02:33Z","timestamp":1595656953000},"page":"2033-2047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Understanding the Role of Inflammasomes in Rheumatoid Arthritis"],"prefix":"10.1007","volume":"43","author":[{"given":"Rashita","family":"Makkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-7708","authenticated-orcid":false,"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1209202","volume":"334","author":"L Abi-Rached","year":"2011","unstructured":"Abi-Rached, L., M.J. Jobin, S. Kulkarni, A. McWhinnie, and K. Dalva. 2011. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science. 334: 89\u201394.","journal-title":"Science."},{"issue":"2","key":"1301_CR2","first-page":"19","volume":"61","author":"B Ani\u0107","year":"2014","unstructured":"Ani\u0107, B., and M. Mayer. 2014. Pathogenesis of rheumatoid arthritis. Reumatizam. 61 (2): 19\u201323.","journal-title":"Reumatizam."},{"key":"1301_CR3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423: 356\u2013361.","journal-title":"Nature."},{"key":"1301_CR4","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J.S., D. Aletaha, and I.B. McInnes. 2016. Rheumatoid arthritis. Lancet 388: 2023\u20132038.","journal-title":"Lancet"},{"key":"1301_CR5","first-page":"295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky, A. 2012. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18: 295\u2013302.","journal-title":"Am J Manag Care"},{"issue":"3","key":"1301_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BOR.0b013e32834518a3","volume":"23","author":"FA Cooles","year":"2011","unstructured":"Cooles, F.A., and J.D. Isaacs. 2011. Pathophysiology of rheumatoid arthritis. Current opinion in rheumatology. 23 (3): 233\u2013240.","journal-title":"Current opinion in rheumatology."},{"issue":"1","key":"1301_CR7","first-page":"46","volume":"67","author":"A Garc\u00eda-Gonz\u00e1lez","year":"2015","unstructured":"Garc\u00eda-Gonz\u00e1lez, Adolfo, Ram\u00f3n Gaxiola-Robles, and Tania Zenteno-Sav\u00edn. 2015. Oxidative stress in patients with rheumatoid arthritis. Revista de Investigaci\u00f3n Cl\u00ednica. 67 (1): 46\u201353.","journal-title":"Revista de Investigaci\u00f3n Cl\u00ednica."},{"key":"1301_CR8","doi-asserted-by":"crossref","unstructured":"Alippe Y, Mbalaviele G, 2019. Omnipresence of inflammasome activities in inflammatory bone diseases. In Seminars in immunopathology. Springer Berlin Heidelberg. pp. 1\u201312.","DOI":"10.1007\/s00281-019-00753-4"},{"key":"1301_CR9","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Frausto G, Medina-Rosales MN, Uresti-Rivera EE, Baranda-C\u00e1ndido L, Zapata-Z\u00fa\u00f1iga M, Basti\u00e1n Y, Amaro RG, Enciso-Moreno JA, Garc\u00eda-Hern\u00e1ndez MH, 2019. Expression and activity of AIM2-inflammasome in rheumatoid arthritis patients. Immunobiology.","DOI":"10.1016\/j.imbio.2019.11.015"},{"key":"1301_CR10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"S Kate","year":"2010","unstructured":"Kate, S., and T. Jurg. 2010. The inflammasomes. Cell 140: 821\u2013832.","journal-title":"Cell"},{"key":"1301_CR11","first-page":"1","volume":"25","author":"X Dong","year":"2019","unstructured":"Dong, X., Z. Zheng, P. Lin, X. Fu, F. Li, J. Jiang, and P. Zhu. 2019. ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cellular & Molecular Immunology 25: 1.","journal-title":"Cellular & Molecular Immunology"},{"issue":"3","key":"1301_CR12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jbspin.2015.07.006","volume":"83","author":"Z Yang","year":"2016","unstructured":"Yang, Z., J. Cao, C. Yu, Q. Yang, Y. Zhang, and L. Han. 2016. Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner. Joint, Bone, Spine 83 (3): 282\u2013289.","journal-title":"Joint, Bone, Spine"},{"issue":"1","key":"1301_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","volume":"17","author":"C Choulaki","year":"2015","unstructured":"Choulaki, C., G. Papadaki, A. Repa, E. Kampouraki, K. Kambas, K. Ritis, G. Bertsias, D.T. Boumpas, and P. Sidiropoulos. 2015. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Research & Therapy 17 (1): 257.","journal-title":"Arthritis Research & Therapy"},{"issue":"10","key":"1301_CR14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3899\/jrheum.141529","volume":"42","author":"A Kastbom","year":"2015","unstructured":"Kastbom, A., L. \u00c4rlestig, and S. Rantap\u00e4\u00e4-Dahlqvist. 2015. Genetic variants of the NLRP3 inflammasome are associated with stroke in patients with rheumatoid arthritis. The Journal of Rheumatology. 42 (10): 1740\u20131745.","journal-title":"The Journal of Rheumatology."},{"key":"1301_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/pr.114.009639","volume":"67","author":"S Siebert","year":"2015","unstructured":"Siebert, S., A. Tsoukas, J. Robertson, and I. McInnes. 2015. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev 67: 280\u2013309.","journal-title":"Pharmacol Rev"},{"issue":"23","key":"1301_CR16","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1242\/jcs.207365","volume":"130","author":"A Malik","year":"2017","unstructured":"Malik, A., and T.D. Kanneganti. 2017. Inflammasome activation and assembly at a glance. Journal of Cell Science 130 (23): 3955\u20133963.","journal-title":"Journal of Cell Science"},{"issue":"7","key":"1301_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo, H., J.B. Callaway, and J.P. Ting. 2015. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nature medicine. 21 (7): 677\u2013687.","journal-title":"Nature medicine."},{"key":"1301_CR18","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen, J.S., D. Aletaha, M. Koeller, M.H. Weisman, and P. Emery. 2007. New therapies for treatment of rheumatoid arthritis. Lancet 370: 1861\u20131874.","journal-title":"Lancet"},{"key":"1301_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz, E., T.S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews. Immunology 13: 397\u2013411.","journal-title":"Nature Reviews. Immunology"},{"key":"1301_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/BOR.0000000000000277","volume":"28","author":"J Dekkers","year":"2016","unstructured":"Dekkers, J., R.E. Toes, T.W. Huizinga, and D. van der Woude. 2016. The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis. Current Opinion in Rheumatology 28: 275\u2013281.","journal-title":"Current Opinion in Rheumatology"},{"key":"1301_CR21","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I.B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. N Engl J Med 365: 2205\u20132219.","journal-title":"N Engl J Med"},{"key":"1301_CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell. 140: 821\u2013832.","journal-title":"Cell."},{"key":"1301_CR23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2006.09.006","volume":"126","author":"M Saleh","year":"2006","unstructured":"Saleh, M. 2006. Caspase-1 builds a new barrier to infection. Cell. 126: 1028\u20131030.","journal-title":"Cell."},{"key":"1301_CR24","first-page":"a008680","volume":"5","author":"M Poreba","year":"2013","unstructured":"Poreba, M., A. Strozyk, G.S. Salvesen, et al. 2013. Caspase substrates and inhibitors. Perspect Biol. 5: a008680.","journal-title":"Perspect Biol."},{"key":"1301_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","volume":"48","author":"LA Joosten","year":"2003","unstructured":"Joosten, L.A., T.R. Radstake, E. Lubberts, et al. 2003. Association of interleukin-18 expres-sion with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. ArthritisRheum. 48: 339\u2013347.","journal-title":"ArthritisRheum."},{"key":"1301_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, and J.H. Stone. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58: 15\u201325.","journal-title":"Arthritis Rheum"},{"key":"1301_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.it.2011.02.002","volume":"32","author":"MH Zaki","year":"2011","unstructured":"Zaki, M.H., M. Lamkanfi, and T.D. Kanneganti. 2011. The Nlrp3 inflammasome: contributionsto intestinal homeostasis. Trends Immunol 32: 171\u2013179.","journal-title":"Trends Immunol"},{"key":"1301_CR28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","volume":"73","author":"RJ Mathews","year":"2014","unstructured":"Mathews, R.J., J.I. Robinson, M. Battellino, et al. 2014. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variantswithin the NLRP3-inflammasome complex in relation to susceptibilityto RA and response to anti-TNF treatment. Ann Rheum Dis 73: 1202\u20131210.","journal-title":"Ann Rheum Dis"},{"key":"1301_CR29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen, I.C., E.M. TeKippe, R.M. Woodford, et al. 2010. The NLRP3 inflammasome functionsas a negative regulator of tumorigenesis during colitis-associated cancer. J ExpMed 207: 1045\u20131056.","journal-title":"J ExpMed"},{"key":"1301_CR30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ibd.21478","volume":"17","author":"SA Hirota","year":"2011","unstructured":"Hirota, S.A., J. Ng, A. Lueng, et al. 2011. NLRP3 inflammasome plays a key rolein the regulation of intestinal homeostasis. Inflamm Bowel Dis 17: 1359\u20131372.","journal-title":"Inflamm Bowel Dis"},{"key":"1301_CR31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol Cell 10: 417\u2013426.","journal-title":"Mol Cell"},{"key":"1301_CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan, S., K. Newton, D.M. Monack, D. Vucic, D.M. French, W.P. Lee, M. Roose-Girma, S. Erickson, and V.M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 430: 213\u2013218.","journal-title":"Nature."},{"key":"1301_CR33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature10510","volume":"477","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., J. Yang, J. Shi, Y.N. Gong, Q. Lu, H. Xu, L. Liu, and F. Shao. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature. 477: 596\u2013600.","journal-title":"Nature."},{"key":"1301_CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","volume":"452","author":"DA Muruve","year":"2008","unstructured":"Muruve, D.A., V. Petrilli, A.K. Zaiss, L.R. White, S.A. Clark, P.J. Ross, R.J. Parks, and J. Tschopp. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 452: 103\u2013107.","journal-title":"Nature."},{"key":"1301_CR35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-010-9419-0","volume":"30","author":"ES Alnemri","year":"2010","unstructured":"Alnemri, E.S. 2010. Sensing cytoplasmic danger signals by the inflammasome. J Clin Immunol 30: 512\u2013519.","journal-title":"J Clin Immunol"},{"key":"1301_CR36","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.1103355","volume":"188","author":"MS Shin","year":"2012","unstructured":"Shin, M.S., Y. Kang, N. Lee, S.H. Kim, K.S. Kang, R. Lazova, and I. Kang. 2012. U1- small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol 188: 4769\u20134775.","journal-title":"J Immunol"},{"key":"1301_CR37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3899\/jrheum.130310","volume":"41","author":"Q Yang","year":"2014","unstructured":"Yang, Q., C. Yu, Z. Yang, Q. Wei, K. Mu, Y. Zhang, W. Zhao, X. Wang, W. Huai, and L. Han. 2014. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus. J Rheumatol 41: 444\u2013452.","journal-title":"J Rheumatol"},{"key":"1301_CR38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.intimp.2013.05.027","volume":"17","author":"J Zhao","year":"2013","unstructured":"Zhao, J., H. Zhang, Y. Huang, H. Wang, S. Wang, C. Zhao, Y. Liang, and N. Yang. 2013. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-\u03baB activation. Int Immunopharmacol 17: 116\u2013122.","journal-title":"Int Immunopharmacol"},{"key":"1301_CR39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fimmu.2012.00414","volume":"3","author":"A Gombault","year":"2013","unstructured":"Gombault, A., L. Baron, and I. Couillin. 2013. ATP release and purinergic signaling in NLRP3 inflammasome activation. Frontiers in Immunology 3: 414.","journal-title":"Frontiers in Immunology"},{"key":"1301_CR40","volume":"10","author":"L Niu","year":"2015","unstructured":"Niu, L., S. Zhang, J. Wu, L. Chen, and Y. Wang. 2015. Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients. PLoS One 10: e0126277.","journal-title":"PLoS One"},{"key":"1301_CR41","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.4049\/jimmunol.0713552","volume":"183","author":"JW Griffith","year":"2009","unstructured":"Griffith, J.W., T. Sun, M.T. McIntosh, and R. Bucala. 2009. Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. Journal of Immunology 183: 5208\u20135220.","journal-title":"Journal of Immunology"},{"key":"1301_CR42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature07965","volume":"459","author":"O Gross","year":"2009","unstructured":"Gross, O., H. Poeck, M. Bscheider, C. Dostert, N. Hannesschl\u00e4ger, S. Endres, G. Hartmann, A. Tardivel, E. Schweighoffer, V. Tybulewicz, et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433\u2013436.","journal-title":"Nature"},{"key":"1301_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature08100","volume":"460","author":"G Guarda","year":"2009","unstructured":"Guarda, G., C. Dostert, F. Staehli, K. Cabalzar, R. Castillo, A. Tardivel, P. Schneider, and J. Tschopp. 2009. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460: 269\u2013273.","journal-title":"Nature"},{"key":"1301_CR44","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1242\/jcs.051193","volume":"122","author":"D Arnoult","year":"2009","unstructured":"Arnoult, D., F. Soares, I. Tattoli, C. Castanier, D.J. Philpott, and S.E. Girardin. 2009. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. Journal of Cell Science 122: 3161\u20133168.","journal-title":"Journal of Cell Science"},{"issue":"2","key":"1301_CR45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell 10 (2): 417\u2013426.","journal-title":"Molecular Cell"},{"issue":"10","key":"1301_CR46","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"CA Dinarello","year":"2019","unstructured":"Dinarello, C.A. 2019. The IL-1 family of cytokines and receptors in rheumatic diseases. Nature Reviews Rheumatology 15 (10): 612\u2013632.","journal-title":"Nature Reviews Rheumatology"},{"issue":"7","key":"1301_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P., and V.M. Dixit. 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nature Reviews. Immunology 16 (7): 407\u2013420.","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"1301_CR48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11926-018-0750-4","volume":"20","author":"CR Harapas","year":"2018","unstructured":"Harapas, C.R., A. Steiner, S. Davidson, and S.L. Masters. 2018. An update on autoinflammatory diseases: inflammasomopathies. Current Rheumatology Reports 20 (7): 40.","journal-title":"Current Rheumatology Reports"},{"key":"1301_CR49","doi-asserted-by":"crossref","unstructured":"Latz E, Duewell P, 2018. NLRP3 inflammasome activation in inflammaging. Semin Immunol.40:61-73.","DOI":"10.1016\/j.smim.2018.09.001"},{"key":"1301_CR50","doi-asserted-by":"crossref","first-page":"102299","DOI":"10.1016\/j.jaut.2019.06.010","volume":"103","author":"JI Shin","year":"2019","unstructured":"Shin, J.I., K.H. Lee, Y.H. Joo, et al. 2019. Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review. J Autoimmun 103: 102299.","journal-title":"J Autoimmun"},{"issue":"8","key":"1301_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2005.06.004","volume":"26","author":"F Martinon","year":"2005","unstructured":"Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends in Immunology 26 (8): 447\u2013454.","journal-title":"Trends in Immunology"},{"issue":"2","key":"1301_CR52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chom.2019.07.020","volume":"26","author":"H Burdett","year":"2019","unstructured":"Burdett, H., A.R. Bentham, S.J. Williams, P.N. Dodds, P.A. Anderson, M.J. Banfield, and B. Kobe. 2019. The plant \u201cResistosome\u201d: structural insights into immune signaling. Cell Host & Microbe 26 (2): 193\u2013201.","journal-title":"Cell Host & Microbe"},{"issue":"6435","key":"1301_CR53","doi-asserted-by":"crossref","first-page":"eaav5870","DOI":"10.1126\/science.aav5870","volume":"364","author":"J Wang","year":"2019","unstructured":"Wang, J., M. Hu, J. Wang, et al. 2019. Reconstitution and structure of a plant NLR resistosome conferring immunity. Science 364 (6435): eaav5870.","journal-title":"Science"},{"issue":"10","key":"1301_CR54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/iub.1210","volume":"65","author":"JA MacDonald","year":"2013","unstructured":"MacDonald, J.A., C.P. Wijekoon, K.C. Liao, and D.A. Muruve. 2013. Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins. IUBMB Life 65 (10): 851\u2013862.","journal-title":"IUBMB Life"},{"issue":"1","key":"1301_CR55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.12607","volume":"281","author":"JA Duncan","year":"2018","unstructured":"Duncan, J.A., and S.W. Canna. 2018. The NLRC4 inflammasome. Immunological Reviews 281 (1): 115\u2013123.","journal-title":"Immunological Reviews"},{"issue":"9","key":"1301_CR56","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","volume":"14","author":"V Petrilli","year":"2007","unstructured":"Petrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death and Differentiation 14 (9): 1583\u20131589.","journal-title":"Cell Death and Differentiation"},{"issue":"7734","key":"1301_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","volume":"564","author":"J Chen","year":"2018","unstructured":"Chen, J., and Z.J. Chen. 2018. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 564 (7734): 71\u201376.","journal-title":"Nature."},{"issue":"8","key":"1301_CR58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K.V., M. Deng, and J.P. Ting. 2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews. Immunology 19 (8): 477\u2013489.","journal-title":"Nature Reviews. Immunology"},{"issue":"3","key":"1301_CR59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman, H.M., J.L. Mueller, D.H. Broide, A.A. Wanderer, and R.D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle- Wells syndrome. Nature Genetics 29 (3): 301\u2013305.","journal-title":"Nature Genetics"},{"issue":"3","key":"1301_CR60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri, L.M., and H.M. Hoffman. 2019. CAPS and NLRP3. Journal of Clinical Immunology 39 (3): 277\u2013286.","journal-title":"Journal of Clinical Immunology"},{"issue":"3","key":"1301_CR61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini, L., F. Martinon, K. Burns, M.F. McDermott, P.N. Hawkins, and J. Tschopp. 2004. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20 (3): 319\u2013325.","journal-title":"Immunity."},{"issue":"2","key":"1301_CR62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng1724","volume":"38","author":"ED Boyden","year":"2006","unstructured":"Boyden, E.D., and W.F. Dietrich. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genetics 38 (2): 240\u2013244.","journal-title":"Nature Genetics"},{"issue":"3","key":"1301_CR63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.chembiol.2017.12.013","volume":"25","author":"MC Okondo","year":"2018","unstructured":"Okondo, M.C., S.D. Rao, C.Y. Taabazuing, et al. 2018. Inhibition of Dpp8\/9 activates the Nlrp1b inflammasome. Cell Chem Biol 25 (3): 262\u2013267 e5.","journal-title":"Cell Chem Biol"},{"key":"1301_CR64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coi.2019.04.015","volume":"60","author":"PS Mitchell","year":"2019","unstructured":"Mitchell, P.S., A. Sandstrom, and R.E. Vance. 2019. The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries. Current Opinion in Immunology 60: 37\u201345.","journal-title":"Current Opinion in Immunology"},{"issue":"1","key":"1301_CR65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2016.09.001","volume":"167","author":"FL Zhong","year":"2016","unstructured":"Zhong, F.L., O. Mama\u00ef, L. Sborgi, et al. 2016. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 167 (1): 187\u2013202 e17.","journal-title":"Cell"},{"issue":"7","key":"1301_CR66","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/annrheumdis-2016-210021","volume":"76","author":"S Grandemange","year":"2017","unstructured":"Grandemange, S., E. Sanchez, P. Louis-Plence, F. Tran Mau-Them, D. Bessis, C. Coubes, E. Frouin, M. Seyger, M. Girard, J. Puechberty, V. Costes, M. Rodi\u00e8re, A. Carbasse, E. Jeziorski, P. Portales, G. Sarrabay, M. Mondain, C. Jorgensen, F. Apparailly, E. Hoppenreijs, I. Touitou, and D. Genevi\u00e8ve. 2017. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Annals of the Rheumatic Diseases 76 (7): 1191\u20131198.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"1301_CR67","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"356","author":"Y Jin","year":"2007","unstructured":"Jin, Y., C.M. Mailloux, K. Gowan, S.L. Riccardi, G. LaBerge, D.C. Bennett, P.R. Fain, and R.A. Spritz. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. The New England Journal of Medicine 356 (12): 1216\u20131225.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"1301_CR68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jmb.2017.07.012","volume":"430","author":"CH Yu","year":"2018","unstructured":"Yu, C.H., J. Moecking, M. Geyer, and S.L. Masters. 2018. Mechanisms of NLRP1- mediated autoinflammatory disease in humans and mice. Journal of Molecular Biology 430 (2): 142\u2013152.","journal-title":"Journal of Molecular Biology"},{"issue":"34","key":"1301_CR69","doi-asserted-by":"crossref","first-page":"32220","DOI":"10.1074\/jbc.M100433200","volume":"276","author":"N Pathan","year":"2001","unstructured":"Pathan, N., H. Marusawa, M. Krajewska, S.I. Matsuzawa, H. Kim, K. Okada, S. Torii, S. Kitada, S. Krajewski, K. Welsh, F. Pio, A. Godzik, and J.C. Reed. 2001. TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. The Journal of Biological Chemistry 276 (34): 32220\u201332229.","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"1301_CR70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ejhg.5201996","volume":"16","author":"RD Bagnall","year":"2008","unstructured":"Bagnall, R.D., R.G. Roberts, M.M. Mirza, T. Torigoe, N.J. Prescott, and C.G. Mathew. 2008. Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation. European Journal of Human Genetics 16 (5): 619\u2013625.","journal-title":"European Journal of Human Genetics"},{"issue":"8","key":"1301_CR71","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","volume":"24","author":"DC Johnson","year":"2018","unstructured":"Johnson, D.C., C.Y. Taabazuing, M.C. Okondo, et al. 2018. DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 24 (8): 1151\u20131156.","journal-title":"Nat Med."},{"issue":"1","key":"1301_CR72","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar4483","volume":"16","author":"S Ito","year":"2014","unstructured":"Ito, S., Y. Hara, and T. Kubota. 2014. CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction. Arthritis Research & Therapy 16 (1): R52.","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"1301_CR73","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.4049\/jimmunol.179.7.4867","volume":"179","author":"A Fontalba","year":"2007","unstructured":"Fontalba, A., V. Martinez-Taboada, O. Gutierrez, C. Pipaon, N. Benito, A. Balsa, R. Blanco, and J.L. Fernandez-Luna. 2007. Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. Journal of Immunology 179 (7): 4867\u20134873.","journal-title":"Journal of Immunology"},{"key":"1301_CR74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","volume":"452","author":"DA Muruve","year":"2008","unstructured":"Muruve, D.A., V. P\u00e9trilli, A.K. Zaiss, L.R. White, S.A. Clark, P.J. Ross, R.J. Parks, and J. Tschopp. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103\u2013107.","journal-title":"Nature"},{"key":"1301_CR75","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/IAI.00730-09","volume":"77","author":"ZL Newman","year":"2009","unstructured":"Newman, Z.L., S.H. Leppla, and M. Moayeri. 2009. CA-074Me protection against anthrax lethal toxin. Infection and Immunity 77: 4327\u20134336.","journal-title":"Infection and Immunity"},{"key":"1301_CR76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/art.38225","volume":"66","author":"JM Kahlenberg","year":"2014","unstructured":"Kahlenberg, J.M., S. Yalavarthi, W. Zhao, J.B. Hodgin, T.J. Reed, N.M. Tsuji, and M.J. Kaplan. 2014. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis & Rhematology 66: 152\u2013162.","journal-title":"Arthritis & Rhematology"},{"key":"1301_CR77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan, V., E. Gracey, M.A. Brown, R.D. Inman, and N. Haroon. 2017. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nature Reviews Rheumatology 13: 359\u2013367.","journal-title":"Nature Reviews Rheumatology"},{"key":"1301_CR78","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland, G., J.T. Gran, and J.C. Nossent. 2011. Increased mortality in ankylosing spondylitis is related to disease activity. Annals of the Rheumatic Diseases 70: 1921\u20131925.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1301_CR79","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"ME Costello","year":"2015","unstructured":"Costello, M.E., F. Ciccia, D. Willner, N. Warrington, P.C. Robinson, B. Gardiner, M. Marshall, T.J. Kenna, G. Triolo, and M.A. Brown. 2015. Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis & Rhematology 67: 686\u2013691.","journal-title":"Arthritis & Rhematology"},{"key":"1301_CR80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man, S.M., R. Karki, and T.D. Kanneganti. 2017. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277: 61\u201375.","journal-title":"Immunol Rev"},{"key":"1301_CR81","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pathol.4.110807.092239","volume":"4","author":"G Chen","year":"2009","unstructured":"Chen, G., M.H. Shaw, Y.G. Kim, and G. Nunez. 2009. NOD-like receptors: Role in innate immunity and inflammatory disease. Annu Rev Pathol 4: 365\u2013398.","journal-title":"Annu Rev Pathol"},{"key":"1301_CR82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/TACG.S37325","volume":"7","author":"FW Tsui","year":"2014","unstructured":"Tsui, F.W., H.W. Tsui, A. Akram, N. Haroon, and R.D. Inman. 2014. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet 7: 105\u2013115.","journal-title":"Appl Clin Genet"},{"key":"1301_CR83","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G.Y., and G. Nunez. 2010. Sterile inflammation: sensing and reacting to damage. Nature Reviews. Immunology 10: 826\u2013837.","journal-title":"Nature Reviews. Immunology"},{"key":"1301_CR84","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell. 140: 805\u2013820.","journal-title":"Cell."},{"key":"1301_CR85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi, M., and V.M. Dixit. 2012. Inflammasomes and their roles in health and disease. Annual Review of Cell and Developmental Biology 28: 137\u2013161.","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"1301_CR86","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., J. Henao-Mejia, E. Elinav, and R. Flavell. 2012. Inflammasomes in health and disease. Nature 481: 278\u2013286.","journal-title":"Nature"},{"key":"1301_CR87","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2013.08.037","volume":"39","author":"H Wen","year":"2013","unstructured":"Wen, H., E.A. Miao, and J.P. Ting. 2013. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39: 432\u2013441.","journal-title":"Immunity"},{"key":"1301_CR88","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","volume":"25","author":"SK Vanaja","year":"2015","unstructured":"Vanaja, S.K., V.A. Rathinam, and K.A. Fitzgerald. 2015. Mechanisms of inflammasome activation: recent advances and novel insights. Trends in Cell Biology 25: 308\u2013315.","journal-title":"Trends in Cell Biology"},{"key":"1301_CR89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi, M., and V.M. Dixit. 2014. Mechanisms and functions of inflammasomes. Cell 157: 1013\u20131022.","journal-title":"Cell"},{"key":"1301_CR90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala, F.S., S. Haasken, and S.L. Cassel. 2014. Mechanism of NLRP3 inflammasome activation. Annals of the New York Academy of Sciences 1319: 82\u201395.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"1301_CR91","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell 10: 417\u2013426.","journal-title":"Molecular Cell"},{"key":"1301_CR92","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1097-2765(00)80032-5","volume":"1","author":"X Yang","year":"1998","unstructured":"Yang, X., H.Y. Chang, and D. Baltimore. 1998. Autoproteolytic activation of pro-caspases by oligomerization. Molecular Cell 1: 319\u2013325.","journal-title":"Molecular Cell"},{"key":"1301_CR93","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.4049\/jimmunol.147.9.2964","volume":"147","author":"AD Howard","year":"1991","unstructured":"Howard, A.D., et al. 1991. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. Journal of Immunology 147: 2964\u20132969.","journal-title":"Journal of Immunology"},{"key":"1301_CR94","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","volume":"275","author":"Y Gu","year":"1997","unstructured":"Gu, Y., et al. 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275: 206\u2013209.","journal-title":"Science"},{"key":"1301_CR95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/386619a0","volume":"386","author":"T Ghayur","year":"1997","unstructured":"Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, W. Wong, R. Kamen, D. Tracey, and H. Alien. 1997. Caspase-1 processes IFN-\u03b3-inducing factor and regulates LPS-induced IFN-\u03b3 production. Nature 386: 619\u2013623.","journal-title":"Nature"},{"key":"1301_CR96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coi.2015.01.010","volume":"32","author":"RE Vance","year":"2015","unstructured":"Vance, R.E. 2015. The NAIP\/NLRC4 inflammasomes. Current Opinion in Immunology 32: 84\u201389.","journal-title":"Current Opinion in Immunology"},{"key":"1301_CR97","volume":"9","author":"X Li","year":"2014","unstructured":"Li, X., Y. Zhang, M. Xia, E. Gulbins, K.M. Boini, and P.L. Li. 2014. Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis. PLoS One 9: e87552.","journal-title":"PLoS One"},{"key":"1301_CR98","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., J. Henao-Mejia, E. Elinav, and R. Flavell. 2012. Inflammasomes in health and disease. Nature. 481: 278\u2013286.","journal-title":"Nature."},{"key":"1301_CR99","doi-asserted-by":"crossref","first-page":"e75457","DOI":"10.1371\/journal.pone.0075457","volume":"8","author":"B Sahdo","year":"2013","unstructured":"Sahdo, B., K. Fransen, B. Asfaw Idosa, P. Eriksson, B. Soderquist, A. Kelly, et al. 2013. Cytokine profile in a cohort of healthy blood donors carrying polymorphisms in genes encoding the NLRP3 inflammasome. PLoS One 8: e75457.","journal-title":"PLoS One"},{"key":"1301_CR100","doi-asserted-by":"crossref","first-page":"e34977","DOI":"10.1371\/journal.pone.0034977","volume":"7","author":"D Verma","year":"2012","unstructured":"Verma, D., E. Sarndahl, H. Andersson, P. Eriksson, M. Fredrikson, J.I. Jonsson, et al. 2012. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1\u03b2 and IL-18 production. PLoS One 7: e34977.","journal-title":"PLoS One"},{"key":"1301_CR101","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar4483","volume":"16","author":"S Ito","year":"2014","unstructured":"Ito, S., Y. Hara, and T. Kubota. 2014. CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction. Arthritis Research & Therapy 16: R52.","journal-title":"Arthritis Research & Therapy"},{"key":"1301_CR102","doi-asserted-by":"crossref","unstructured":"Huang Y, Jiang H, Chen Y, et al., 2018. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med.;10(4):pii: e8689.","DOI":"10.15252\/emmm.201708689"},{"key":"1301_CR103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","volume":"91","author":"S Darakhshan","year":"2015","unstructured":"Darakhshan, S., and A.B. Pour. 2015. Tranilast: a review of its therapeutic applications. Pharmacological Research 91: 15\u201328.","journal-title":"Pharmacological Research"},{"issue":"9","key":"1301_CR104","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/kem160","volume":"46","author":"JJ Inglis","year":"2007","unstructured":"Inglis, J.J., G. Criado, M. Andrews, M. Feldmann, R.O. Williams, and M.L. Selley. 2007. The anti-allergic drug, N-(3\u2032,4\u2032-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. Rheumatology (Oxford, England) 46 (9): 1428\u20131432.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"3","key":"1301_CR105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1476-5381.2009.00561.x","volume":"159","author":"N Shiota","year":"2010","unstructured":"Shiota, N., P.T. Kovanen, K.K. Eklund, N. Shibata, K. Shimoura, T. Niibayashi, C. Shimbori, and H. Okunishi. 2010. The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice. British Journal of Pharmacology 159 (3): 626\u2013635.","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"1301_CR106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1254\/jphs.FP0070534","volume":"105","author":"T Nagate","year":"2007","unstructured":"Nagate, T., T. Tamura, F. Sato, J. Kuroda, J. Nakayama, and N. Shibata. 2007. Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats. Journal of Pharmacological Sciences 105 (1): 48\u201356.","journal-title":"Journal of Pharmacological Sciences"},{"issue":"11","key":"1301_CR107","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H., H. He, Y. Chen, W. Huang, J. Cheng, J. Ye, A. Wang, J. Tao, C. Wang, Q. Liu, T. Jin, W. Jiang, X. Deng, and R. Zhou. 2017. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. The Journal of Experimental Medicine 214 (11): 3219\u20133238.","journal-title":"The Journal of Experimental Medicine"},{"issue":"12","key":"1301_CR108","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4402221","volume":"14","author":"P Karki","year":"2007","unstructured":"Karki, P., C. Seong, J.-E. Kim, K. Hur, S.Y. Shin, J.S. Lee, B. Cho, and I.S. Park. 2007. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death and Differentiation 14 (12): 2068\u20132075.","journal-title":"Cell Death and Differentiation"},{"key":"1301_CR109","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","volume":"80","author":"H Kallberg","year":"2007","unstructured":"Kallberg, H., L. Padyukov, and R.M. Plenge. 2007. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. American Journal of Human Genetics 80: 867\u2013875.","journal-title":"American Journal of Human Genetics"},{"key":"1301_CR110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog, L., P. Stolt, and K. Lundberg. 2006. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis and Rheumatism 54: 38\u201346.","journal-title":"Arthritis and Rheumatism"},{"key":"1301_CR111","doi-asserted-by":"crossref","unstructured":"Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K. & Pillemer, S. R, 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis and Rheumatism 58(1); 15\u201325.","DOI":"10.1002\/art.23177"},{"issue":"1","key":"1301_CR112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2010","unstructured":"Lawrence, R.C., D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, and J.M. Jordan. 2010. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis and Rheumatism 58 (1): 26\u201335.","journal-title":"Arthritis and Rheumatism"},{"key":"1301_CR113","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., J. Henao-Mejia, E. Elinav, and R. Flavell. 2012. Inflammasomes in health and disease. Nature. 481: 278\u2013286.","journal-title":"Nature."},{"key":"1301_CR114","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright, H.L., R.J. Moots, R.C. Bucknall, and S.W. Edwards. 2010. Neutrophil function in inflammationand inflammatory diseases. Rheumatology. 49: 1618\u20131631.","journal-title":"Rheumatology."},{"issue":"5","key":"1301_CR115","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1073\/pnas.1619730114","volume":"114","author":"JM Urbach","year":"2017","unstructured":"Urbach, J.M., and F.M. Ausubel. 2017. The NBS-LRR architectures of plant R-proteins and metazoan NLRs evolved in independent events. Proceedings of the National Academy of Sciences of the United States of America 114 (5): 1063\u20131068.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"1301_CR116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2004.08.023","volume":"343","author":"DD Leipe","year":"2004","unstructured":"Leipe, D.D., E.V. Koonin, and L. Aravind. 2004. STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. Journal of Molecular Biology 343 (1): 1\u201328.","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"1301_CR117","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/molecules23020474","volume":"23","author":"J Xu","year":"2018","unstructured":"Xu, J., E.A. Wold, Y. Ding, Q. Shen, and J. Zhou. 2018. Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection. Molecules 23 (2): 474.","journal-title":"Molecules"},{"issue":"1","key":"1301_CR118","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He, H., H. Jiang, Y. Chen, J. Ye, A. Wang, C. Wang, Q. Liu, G. Liang, X. Deng, W. Jiang, and R. Zhou. 2018. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nature Communications 9 (1): 2550.","journal-title":"Nature Communications"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-020-01301-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T20:18:49Z","timestamp":1696450729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-020-01301-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s10753-020-01301-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"25 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}